Livanova Stock News

As per our first article, DTD remains incredibly attractive, even with conservative prevalence figures.

Stocks, especially the once high flying technology stocks, had a lousy start to the new year. QQQ lost 9% of its value in January.

LivaNova (LIVN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

LivaNova (LIVN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Accuray (ARAY) delivered earnings and revenue surprises of -100% and 10.84%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Major neurostimulation devices market players include Abbott, Boston Scientific, IntraPace, Laborie, LivaNova, Medtronic, Neuronetics, SPR Therapeutics, Cyberonics, ElectroCore Inc., Aleva Neurotherapeutics SA, Synapse Biomedical Inc., MicroTransponder, RS Medical, Helbling holding Ag, EndoStim Inc., and BioControl Medical. SELBYVILLE, Del. , Jan. 20, 2022 /PRNewswire/ -- The neurostimulation devices market size is anticipated to record a valuation of USD 13.6 billion by 2027, according to the most recent study by Global Market Insights Inc. Increasing adoption and introduction of advanced neurostimulation devices will drive the overall market growth. Increasing demand for minimally invasive surgeries in developed countries attributed to the rising preference among patients for shorter hospital stays and faster recovery will accelerate the neurostimulation devices market expansion. Neurological patients using minimally invasive techniques, have experienced reduced treatment costs, less pain, and speedy recovery.

LivaNova PLC (NASDAQ:LIVN) concluded the trading at $85.24 on Thursday, December 23 with a rise of 0.20% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $85.07 and 5Y monthly beta was reading 0.89 with its price kept floating in the range … Analysts Release Price Targets And Ratings For LivaNova PLC (LIVN) Read More »

State of Michigan Retirement System boosted its position in LivaNova PLC (NASDAQ:LIVN) by 9.0% in the 3rd quarter, HoldingsChannel reports. The firm owned 13,366 shares of the companys stock after purchasing an additional 1,100 shares during the period. State of Michigan Retirement Systems holdings in LivaNova were worth $1,058,000 at the end of the most []

LivaNova PLC (NASDAQ:LIVN) CEO Damien Mcdonald sold 2,784 shares of the firms stock in a transaction dated Monday, December 13th. The stock was sold at an average price of $81.50, for a total transaction of $226,896.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. LIVN []

The global sleep apnea devices market includes major players like CareFusion Corp. (Part of Becton, Dickinson and Company), Summoned, Resmed, Imthera Medical, Inc. (Part of Livanova Plc), Koninklijke Philips N.V.

The Adult and Pediatric Hemoconcentrators Market report aims to convey an inexpensive understanding of the business which has been analyzed by using primary and secondary research strategies. the main purpose of this Adult and Pediatric Hemoconcentrators Market report is to

The Shigella Vaccines Market report aims to convey an inexpensive understanding of the business which has been analyzed by using primary and secondary research strategies. the main purpose of this Shigella Vaccines Market report is to supply an in-depth view

Kestra Private Wealth Services LLC acquired a new stake in shares of LivaNova PLC (NASDAQ:LIVN) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 7,768 shares of the companys stock, valued at approximately $615,000. A number of other institutional investors []